Allergan Seeks Expedited Procedure in Valeant Lawsuit
Allergan, Inc. has asked the
In its preliminary injunction motion,
Allergan’s proposed schedule would require expedited discovery to be completed in
At the Special Meeting,
“The Allergan Board of Directors continues to believe that Valeant’s unsolicited exchange offer is grossly inadequate and substantially undervalues
Source: Allergan